{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T12:30:36Z","timestamp":1787574636330,"version":"build-2736575974"},"reference-count":33,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Universidad Se\u00f1or de Sipan\u2013Vicerrectorado de investigacion"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Med.","JCM"],"abstract":"<jats:p>Background: Inflammation plays a key role in atherosclerosis and thromboinflammatory processes involved in ischemic stroke. Colchicine, an anti-inflammatory agent that inhibits microtubule polymerization and inflammasome activation, has demonstrated cardiovascular benefits in coronary artery disease. However, its effectiveness in secondary prevention after ischemic stroke remains uncertain. We conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) evaluating colchicine in two pre-specified populations: (i) patients with non-cardioembolic ischemic stroke or high-risk transient ischemic attack (TIA), and (ii) atherosclerotic cardiovascular disease (ASCVD) cohorts reporting cerebrovascular outcomes, with pre-planned subgroup and sensitivity analyses restricted to stroke\/TIA-only trials to address indirectness. Methods: We searched PubMed, Scopus, Web of Science, Embase, and the Cochrane Central Register of Controlled Trials (CENTRAL) from inception to 20 October 2025, with no language restrictions, using a fully reported strategy combining controlled vocabulary (MeSH\/Emtree) and free-text terms for colchicine and cerebrovascular\/atherosclerotic outcomes. The primary outcome was recurrent stroke. Secondary outcomes included composite major vascular events, serious adverse events, any adverse events, and treatment discontinuation due to adverse events. A pre-specified subgroup analysis compared stroke\/TIA-dedicated trials versus ASCVD trials reporting cerebrovascular outcomes, and a sensitivity analysis was restricted to stroke\/TIA-only trials. Random-effects meta-analysis was performed using risk ratios (RR) with 95% confidence intervals (CI). Heterogeneity was assessed using the I2 statistic, and the certainty of evidence was evaluated using the GRADE framework. Results: Five randomized controlled trials, including 18,336 participants, were included. Colchicine did not significantly reduce the risk of recurrent stroke compared with control therapy (RR 0.86, 95% CI 0.65\u20131.12). Similarly, no significant reduction in vascular events was observed (RR 0.70, 95% CI 0.40\u20131.23), with substantial heterogeneity across studies. Colchicine was not associated with a significant increase in serious adverse events (RR 1.14, 95% CI 0.43\u20132.97). When restricted to stroke\/TIA-dedicated trials (CHANCE-3, CONVINCE, COPS), the point estimate for recurrent stroke remained close to the null. Across trials reporting tolerability, colchicine was associated with higher rates of gastrointestinal adverse events and study-drug discontinuation, although the magnitude varied across studies. According to GRADE, the certainty of evidence ranged from moderate for recurrent stroke to low for vascular events and serious adverse events. Conclusions: Colchicine did not significantly reduce recurrent stroke or vascular events in patients with ischemic stroke or transient ischemic attack. Current evidence does not support routine use of colchicine for secondary stroke prevention, and further randomized trials are needed to identify potential subgroups that may benefit from anti-inflammatory therapy.<\/jats:p>","DOI":"10.3390\/jcm15176528","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T11:47:19Z","timestamp":1787572039000},"page":"6528","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Colchicine in Patients with Acute Ischemic Stroke: A Meta-Analysis of Randomized Trials"],"prefix":"10.3390","volume":"15","author":[{"given":"Joshuan J.","family":"Barboza","sequence":"first","affiliation":[{"name":"Vicerrectorado de Investigaci\u00f3n, Universidad Se\u00f1or de Sip\u00e1n, Chiclayo 13009, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6546-3570","authenticated-orcid":false,"given":"Oriana","family":"Rivera-Lozada","sequence":"additional","affiliation":[{"name":"Vicerrectorado de Investigaci\u00f3n, Universidad Se\u00f1or de Sip\u00e1n, Chiclayo 13009, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9sar","family":"Bonilla-Asalde","sequence":"additional","affiliation":[{"name":"Vicerrectorado de Investigaci\u00f3n, Universidad Se\u00f1or de Sip\u00e1n, Chiclayo 13009, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5261-018X","authenticated-orcid":false,"given":"Luis G.","family":"Chancha-Mart\u00ednez","sequence":"additional","affiliation":[{"name":"Facultad de Ciencias de la Salud, Universidad Cient\u00edfica del Sur, Lima 15047, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5452-9005","authenticated-orcid":false,"given":"V\u00edctor A.","family":"Ma\u00f1uico-Antay","sequence":"additional","affiliation":[{"name":"Facultad de Ciencias de la Salud, Universidad Cient\u00edfica del Sur, Lima 15047, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3847-9851","authenticated-orcid":false,"given":"Alexis","family":"Ccoyllo-Mayhuasca","sequence":"additional","affiliation":[{"name":"Facultad de Ciencias de la Salud, Universidad Cient\u00edfica del Sur, Lima 15047, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7631-2834","authenticated-orcid":false,"given":"Luis E.","family":"Balc\u00e1zar-Rinc\u00f3n","sequence":"additional","affiliation":[{"name":"Hospital General de Zona No. 2, Instituto Mexicano del Seguro Social, Ciudad de M\u00e9xico 06800, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0269-4288","authenticated-orcid":false,"given":"Dante Ra\u00fal","family":"Torres-Huaman\u00ed","sequence":"additional","affiliation":[{"name":"Universidad Nacional San Luis Gonzaga, Ica 11001, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3591-449X","authenticated-orcid":false,"given":"Briseidy","family":"Ortiz-Rodr\u00edguez","sequence":"additional","affiliation":[{"name":"Facultad de Ciencias de la Cultura F\u00edsica, Universidad Aut\u00f3noma de Chihuahua, Chihuahua 31000, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4038-0776","authenticated-orcid":false,"given":"Mahycol","family":"Bravo-Ramirez","sequence":"additional","affiliation":[{"name":"Tau Clinical Research Methods Network, Trujillo 13001, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1177\/17474930211065917","article-title":"World Stroke Organization (WSO): Global Stroke Fact Sheet 2022","volume":"17","author":"Feigin","year":"2022","journal-title":"Int. J. Stroke"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/17474930241308142","article-title":"World Stroke Organization: Global Stroke Fact Sheet 2025","volume":"20","author":"Feigin","year":"2025","journal-title":"Int. J. Stroke"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1177\/17474930211019568","article-title":"The state of stroke services across the globe: Report of World Stroke Organization-World Health Organization surveys","volume":"16","author":"Owolabi","year":"2021","journal-title":"Int. J. Stroke"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"117117","DOI":"10.1016\/j.jns.2020.117117","article-title":"Towards evidence-based policies to strengthen acute stroke care in low-middle-income countries","volume":"418","author":"Baatiema","year":"2020","journal-title":"J. Neurol. Sci."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1177\/17474930251351867","article-title":"Prehospital stroke care in low- and middle-income countries: A World Stroke Organization (WSO) scientific statement","volume":"20","author":"Bosch","year":"2025","journal-title":"Int. J. Stroke"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1097\/CCM.0000000000004597","article-title":"Management of Acute Ischemic Stroke","volume":"48","author":"Herpich","year":"2020","journal-title":"Crit. Care Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1161\/CIRCRESAHA.121.319994","article-title":"Immune Pathways in Etiology, Acute Phase, and Chronic Sequelae of Ischemic Stroke","volume":"130","author":"Endres","year":"2022","journal-title":"Circ. Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/cvr\/cvaa211","article-title":"Inflammation and cardiovascular diseases: Lessons from seminal clinical trials","volume":"117","author":"Liberale","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1177\/17474930231207777","article-title":"Targeting inflammation to reduce recurrent stroke","volume":"19","author":"Zietz","year":"2024","journal-title":"Int. J. Stroke"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Zheng, E., Warcho\u0142, I., Mejza, M., Mo\u017cd\u017can, M., Strzemi\u0144ska, M., Bajer, A., Madura, P., \u017bak, J., and Plewka, M. (2025). Exploring Anti-Inflammatory Treatment as Upstream Therapy in the Management of Atrial Fibrillation. J. Clin. Med., 14.","DOI":"10.3390\/jcm14030882"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2459\/JCM.0000000000001290","article-title":"Reply letter to: Correspondence on \u2018Coronavirus disease 2019 in patients with cardiovascular disease\u2019 (J Cardiovasc Med (Hagerstown). 2022 Jan 1;23(1):e42. doi: 10.2459\/JCM.0000000000001276. PMID: 34874340.)","volume":"23","author":"Arcari","year":"2022","journal-title":"J. Cardiovasc. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"103226","DOI":"10.1016\/j.eclinm.2025.103226","article-title":"Colchicine for preventing stroke in patients with and without intracranial atherosclerotic stenosis: A prespecified analysis of a randomized clinical trial","volume":"84","author":"Li","year":"2025","journal-title":"EClinicalMedicine"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s40256-025-00743-y","article-title":"Colchicine for the Secondary Prevention of Cardiovascular Diseases: A Cumulative-Dose Meta-analysis of Randomized Controlled Trials including 31,397 Subjects Worldwide","volume":"26","author":"Li","year":"2026","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1093\/eurheartj\/ehaf174","article-title":"Long-term trials of colchicine for secondary prevention of vascular events: A meta-analysis","volume":"46","author":"Samuel","year":"2025","journal-title":"Eur. Heart J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"108186","DOI":"10.1016\/j.jstrokecerebrovasdis.2024.108186","article-title":"Magnitude of effect of low-dose colchicine, a newly food and drug administration approved treatment for stroke prevention","volume":"34","author":"Escalera","year":"2025","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"102835","DOI":"10.1016\/j.eclinm.2024.102835","article-title":"Colchicine for secondary prevention of ischaemic stroke and atherosclerotic events: A meta-analysis of randomised trials","volume":"76","author":"Fiolet","year":"2024","journal-title":"EClinicalMedicine"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e70020","DOI":"10.1111\/eci.70020","article-title":"Inflammation in atherosclerotic cardiovascular disease: From diagnosis to treatment","volume":"55","author":"Arnold","year":"2025","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/joim.20107","article-title":"Colchicine and cardiovascular events: An updated meta-analysis of published randomized controlled trials","volume":"298","author":"Xie","year":"2025","journal-title":"J. Intern. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2459\/JCM.0000000000001744","article-title":"Colchicine for prevention of major adverse cardiovascular events: A meta-analysis of randomized clinical trials","volume":"26","author":"Ballacci","year":"2025","journal-title":"J. Cardiovasc. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst. Rev."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: A revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jclinepi.2018.01.013","article-title":"GRADE Guidelines: 19. Assessing the certainty of evidence in the importance of outcomes or values and preferences-Risk of bias and indirectness","volume":"111","author":"Zhang","year":"2019","journal-title":"J. Clin. Epidemiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jacc.2012.10.027","article-title":"Low-dose colchicine for secondary prevention of cardiovascular disease","volume":"61","author":"Nidorf","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1161\/CIRCULATIONAHA.120.050771","article-title":"Colchicine in Patients With Acute Coronary Syndrome: The Australian COPS Randomized Clinical Trial","volume":"142","author":"Tong","year":"2020","journal-title":"Circulation"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in Patients with Chronic Coronary Disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e079061","DOI":"10.1136\/bmj-2023-079061","article-title":"Colchicine in patients with acute ischaemic stroke or transient ischaemic attack (CHANCE-3): Multicentre, double blind, randomised, placebo controlled trial","volume":"385","author":"Li","year":"2024","journal-title":"BMJ"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(24)00968-1","article-title":"Long-term colchicine for the prevention of vascular recurrent events in non-cardioembolic stroke (CONVINCE): A randomised controlled trial","volume":"404","author":"Kelly","year":"2024","journal-title":"Lancet"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2441112","DOI":"10.1080\/14017431.2024.2441112","article-title":"The efficacy of colchicine compared to placebo for preventing ischemic stroke among individuals with established atherosclerotic cardiovascular diseases: A systematic review and meta-analysis","volume":"59","author":"Zhu","year":"2025","journal-title":"Scand. Cardiovasc. J."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Li, Y., Cui, R., Fan, F., Lu, Y., Ai, Y., Liu, H., Liu, S., Du, Y., Qin, Z., and Sun, W. (2022). The Efficacy and Safety of Ischemic Stroke Therapies: An Umbrella Review. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.924747"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/s41591-025-04101-y","article-title":"Anticoagulation to prevent ischemic stroke and neurocognitive impairment in atrial fibrillation: The BRAIN-AF randomized clinical trial","volume":"32","author":"Rivard","year":"2026","journal-title":"Nat. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"106288","DOI":"10.1016\/j.ejps.2022.106288","article-title":"Effect of different doses of colchicine on high sensitivity C-reactive protein in patients with acute minor stroke or transient ischemic attack: A pilot randomized controlled trial","volume":"178","author":"Yuan","year":"2022","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e038687","DOI":"10.1161\/JAHA.124.038687","article-title":"Cardiovascular Benefit of Colchicine in Relation to Baseline Risk: A Secondary Analysis of the LoDoCo2 Trial","volume":"14","author":"Mohammadnia","year":"2025","journal-title":"J. Am. Heart Assoc."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jacc.2021.06.037","article-title":"Colchicine in Patients With Chronic Coronary Disease in Relation to Prior Acute Coronary Syndrome","volume":"78","author":"Opstal","year":"2021","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/17\/6528\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T12:10:11Z","timestamp":1787573411000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/17\/6528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,24]]},"references-count":33,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["jcm15176528"],"URL":"https:\/\/doi.org\/10.3390\/jcm15176528","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,24]]}}}